An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...
Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
Rwanda has begun the process to officially declare its Marburg outbreak over after it discharged the last remaining recovered ...
University of Zagreb researcher Beata Halassy treated her breast cancer with an unproven virus-based therapy using viruses ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...